Dr Reddy's launches cancer drug in Canada

"Our launch of Reddy-Lenalidomide represents our firm commitment to providing access to affordable medicines for Canada's Multiple Myeloma and Myelodysplastic Syndrome (MDS) patient population," Vinod Ramachandran, Vice President and General Manager, Dr. Reddy's Laboratories Canada said.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3jBI2UA
via IFTTT